EV-201 Study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. TPS4590-TPS4590 ◽  
Author(s):  
Jonathan E. Rosenberg ◽  
Elisabeth I. Heath ◽  
Peter H. O'Donnell ◽  
Noah M. Hahn ◽  
Arjun Vasant Balar ◽  
...  
2020 ◽  
Vol 37 (1) ◽  
pp. e9-e13
Author(s):  
Bennett Yau-Bun Hong ◽  
Joshua R. Ford ◽  
Isabella C. Glitza ◽  
Carlos A. Torres Cabala ◽  
Michael Tetzlaff ◽  
...  

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 204-LB ◽  
Author(s):  
KARA R. MIZOKAMI-STOUT ◽  
ROMA GIANCHANDANI ◽  
MARK MACEACHERN ◽  
RAVI M. IYENGAR ◽  
SARAH YENTZ ◽  
...  

2018 ◽  
Vol 36 (26) ◽  
pp. 2743-2744 ◽  
Author(s):  
Donald L. Kimpel ◽  
Janet E. Lewis ◽  
Elizabeth Gaughan ◽  
William W. Grosh ◽  
Christiana Brenin

Sign in / Sign up

Export Citation Format

Share Document